ERYTECH announces fast take-off of its Phase IIb study in Acute Myeloid Leukemia

  • Post author:
  • Post category:Newsroom

ERYTECH announces a fast take-off of its Phase IIb study in Acute Myeloid Leukemia (AML).

Menu